Keywords: ucb, starts, trials, novel, asthma, compound, pharma
UCB starts trials of novel asthma compound
Article | 22 July 2002
UCB Pharma, the company behind the well-established antihistamine Zyrtec(cetirizine), has initiated clinical testing of a new and novel treatment ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
